Eli Lilly's Mounjaro becomes India's best-selling medicine at ₹1,256cr
Category: Health
Share
Archive
Like
Eli Lilly's anti-obesity injection, Mounjaro, just became India's best-selling medicine, pulling in ₹1,256 crore over the past year, a massive 502% jump.
This signals a big move away from old-school pills to newer injectable GLP-1 drugs for managing both diabetes and obesity.
A note on cookies
Newshunt uses essential cookies to keep you signed in and to remember your language and country, so the site works the way you expect. With your permission, we'd also like to use analytics cookies to understand how people use Newshunt and improve it over time.
Accepting only affects analytics. To learn more, view our Privacy Policy or Terms & Conditions.
(0)Comments